The reversible addition−fragmentation chain transfer (RAFT) polymerization of N-isopropylacrylamide (NIPAM) was carried out successfully in the absence and presence of Lewis acid
Y(OTf)3 to synthesize controlled molecular weight atactic and isotactic poly(NIPAM)s using both
1-phenylethyl phenyldithioacetate (PEPD) and cumyl phenyldithioacetate (CPDT) as the RAFT agents.
The polymerization rate is about 16 times faster in the presence of the Lewis acid than that in the absence
and 1.4 times faster with PEPD than with CPDT as the RAFT agent. The polymer with a higher
polydispersity was obtained when prepared in the presence of the Lewis acid than that in the absence.
A longer induction period was observed using CPDT than PEPD. The chain-end structure of isotactic
poly(NIPAM) was determined by 1H NMR and MALDI−TOF mass spectrometry. The RAFT agent derived
isotactic poly(NIPAM) was the main product as expected from the well-accepted mechanism of RAFT
polymerization. Moreover, a series of stereoblock [atactic(a)-b-isotactic(i)] poly(NIPAM) with different
block lengths were synthesized via a one-pot synthesis procedure: synthesis of the atactic block in the
absence of the Lewis acid followed by the addition of the Lewis acid to synthesize the isotactic block. The
longer is the isotactic block length, the higher is the meso dyad value of the stereoblock polymer as
expected. We also successfully synthesized the diblock copolymers, a-poly(NIPAM)-b-polystyrene and
i-poly(NIPAM)-b-polystyrene, starting with the atactic and isotactic poly(NIPAM) macro-RAFT agents,
respectively.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.